Post-severe Acute Respiratory Syndrome Coronavirus 2 Monoclonal Antibody Treatment Hospitalizations as a Sentinel for Emergence of Viral Variants in New York City

Kelsie Cowman,Yi Guo,Liise-Anne Pirofski,David Wong,Hongkai Bao,Victor Chen, Una Hopkins,Erin Andrews, Joseph Hamel,Marla Keller, Eran Bellin,Raja Thota,Patricia Davis, Edwin Torres Rodriguez, Pooja Suthar,Lauren Allen,James Rossi, Adam Haviland,Erika Orner,Wendy Szymczak,Sadahf Shujauddin,James McCarthy, Barbara Binder, Vanitha Pushparaj,Linda Bard, Vincent Frank Pierino,Leslie Alsina,David Esses, Alicia McCaskie, Caron Campbell, Tabitha Madzura,Andrew Wollowitz, Kelly Basset,Deborah White,Rafael Ruiz, Frank Sosnowski,Priya Nori

OPEN FORUM INFECTIOUS DISEASES（2021）

引用 9|浏览11

暂无评分

摘要

We partnered with the US Department of Health and Human Services to treat high-risk, nonadmitted coronavirus disease 2019 (COVID-19) patients with bamlanivimab in the Bronx, New York per Emergency Use Authorization criteria. Increasing posttreatment hospitalizations were observed monthly between December 2020 and March 2021 in parallel to the emergence of severe acute respiratory syndrome coronavirus 2 variants in New York City.

查看译文

关键词

antimicrobial stewardship, COVID-19, monoclonal antibodies, SARS-CoV-2 variants

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要